Danaher DHR
NYSE DHR
$212.54 +4.18 (+2.01%)
As of: Sep 17, 2026 · 3:59 PM EDT

Danaher (DHR) EBT Margin (2009 - 2026)

Danaher (DHR) posted EBT Margin of 17.21% for Q2 2026, down 17.09% on a QoQ basis from 20.75% in Q1 2026, and up 617.0% year-over-year from 2.4% in Q2 2025.

Analysis

Danaher (DHR) EBT Margin (2009 - 2026) Analysis & Trends

Danaher has reported EBT Margin for 18 years, with the latest figure at 17.21% in Q2 2026.

  • On a quarterly basis, EBT Margin rose 617.0% year-over-year to 17.21% in Q2 2026; TTM through Jun 2026 was 18.97%, a 199.0% increase from a year earlier, with the FY2025 full-year figure at 17.23%, down 223.0% from the prior year.
  • EBT Margin was 17.21% for Q2 2026 at Danaher, down from 20.75% in the prior quarter.
  • The five-year high for EBT Margin was 32.16% in Q2 2022, with the low at 11.03% in Q2 2025.
  • Average EBT Margin over 5 years is 20.96%, with a median of 19.87% recorded in 2025.
  • The largest YoY upside for EBT Margin was 1073 bps in 2022 against a maximum downside of 1386 bps in 2022.
  • Over 5 years, EBT Margin stood at 14.68% in 2022, then soared by 31 bps to 19.23% in 2023, then increased by 5 bps to 20.11% in 2024, then declined by 0 bps to 20.08% in 2025, then declined by 14 bps to 17.21% in 2026.
  • The last three EBT Margin figures came in at 17.21% (Q2 2026), 20.75% (Q1 2026), and 20.08% (Q4 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBT Margin (Qtr)
1 Thermo Fisher Scientific 241.68 Bn 237.61 Bn 8.34 Bn 16.04%
2 Danaher 147.34 Bn 142.99 Bn 3.61 Bn 17.21%
3 Agilent Technologies 43.34 Bn 41.59 Bn 1.04 Bn 23.64%
4 Illumina 34.58 Bn 33.41 Bn 770.00 Mn 22.43%
5 Revvity 16.31 Bn 15.29 Bn 416.87 Mn 8.71%
6 Bio-Techne 11.28 Bn 11.01 Bn 211.39 Mn 22.01%
7 Bio-Rad Laboratories 10.16 Bn 8.54 Bn 345.80 Mn 83.27%
8 Repligen 9.77 Bn 8.75 Bn 110.04 Mn 6.93%
9 10x Genomics 9.45 Bn 8.90 Bn 112.50 Mn -12.34%
10 Bruker 9.26 Bn 9.04 Bn 416.00 Mn -6.08%
Historic Data

Historic Data

Download Data
DateValue
Jun 26, 2026 17.21%
Mar 27, 2026 20.75%
Dec 31, 2025 20.08%
Sep 26, 2025 17.78%
Jun 27, 2025 11.03%
Mar 28, 2025 19.67%
Dec 31, 2024 20.11%
Sep 27, 2024 16.85%
Jun 28, 2024 18.86%
Mar 29, 2024 21.93%
Dec 31, 2023 19.23%
Sep 29, 2023 20.39%
Jun 30, 2023 19.32%
Mar 31, 2023 25.60%
Dec 31, 2022 14.68%
Sep 30, 2022 29.91%
Jul 1, 2022 31.69%
Apr 1, 2022 32.16%
Dec 31, 2021 28.54%
Oct 1, 2021 19.19%